036480 — Daesung Microbiological Labs Co Income Statement
0.000.00%
Last trade - 00:00- KR₩32bn
- KR₩43bn
- KR₩24bn
Annual income statement for Daesung Microbiological Labs Co, fiscal year end - December 31st, KRW millions except per share, conversion factor applied.
2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | 2024 December 31st | |
|---|---|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
| Source: | Annual Audited Accounts | ARS | Annual Audited Accounts | Annual Audited Accounts | ARS |
| Standards: | IFRS | IFRS | IFRS | IFRS | IFRS |
| Status: | Final | Final | Final | Final | Final |
| Revenue | |||||
| Total Revenue | 24,801 | 23,997 | 25,500 | 25,562 | 23,804 |
| Cost of Revenue | |||||
| Gross Profit | 8,041 | 5,738 | 4,794 | 4,849 | 4,052 |
| Selling / General / Administrative Expenses | |||||
| Depreciation and Amortization | |||||
| Unusual Expense / Income | |||||
| Total Operating Expenses | 22,883 | 23,660 | 25,828 | 26,251 | 25,356 |
| Operating Profit | 1,918 | 337 | -328 | -689 | -1,552 |
| Gain / Loss on Sale of Assets | |||||
| Total Net Non Operating Interest Income / Expense | |||||
| Other Net Non Operating Costs | |||||
| Net Income Before Taxes | 1,529 | 843 | 2,261 | -1,082 | -1,571 |
| Provision for Income Taxes | |||||
| Net Income After Taxes | 1,519 | 866 | 1,703 | -680 | -1,769 |
| Net Income Before Extraordinary Items | |||||
| Net Income | 1,519 | 866 | 1,703 | -680 | -1,769 |
| Income Available to Common Shareholders Excluding Extraordinary Items | |||||
| Income Available to Common Shareholders Including Extraordinary Items | |||||
| Diluted Net Income | 1,519 | 866 | 1,703 | -680 | -1,769 |
| Diluted Weighted Average Shares | |||||
| Basic EPS Including Extraordinary Items | |||||
| Diluted EPS Including Extraordinary Items | |||||
| Diluted EPS Excluding Extraordinary Items | |||||
| Normalised Income Before Taxes | |||||
| Normalised Income After Taxes | |||||
| Normalised Income Available to Common Shareholders | |||||
| Diluted Normalised EPS | 468 | 227 | 8.24 | -179 | -468 |
| Dividends per Share |